Recalls / —
—#105014
Product
Arrow International StimuCath(R) Continuous Nerve Block Kit, ASK-19608-SFH, Lot # MF0127039 Permits placement of catheters next to nerves and nerve plexuses for continuous nerve block anesthesia of analgesia techniques for periods not exceeding 72 hours
- FDA product code
- CAZ — Anesthesia Conduction Kit
- Device class
- Class 2
- Medical specialty
- Anesthesiology
- 510(k) numbers
- K021567
- Affected lot / code info
- Lot number MF0127039
Why it was recalled
Some of the outer trays used in the packaging of the ASK-19608-SFH Continuous Nerve Block Kits, lot # MF0127039 were found to have an insufficient seal. Therefore, the packaging may have been compromised, and sterility of the product cannot be guaranteed.
Root cause (FDA determination)
Packaging
Action the firm took
The firm, Arrow International, sent an "URGENT MEDICAL DEVICE RECALL" letter dated June 20, 2011, to its customer. The letter included a stock response form to be completed and returned to the firm. The letter also described the product, problem and action to be taken. The customer was instructed to check their stock for the products included in the scope of the recall; cease use and distribution; quarantine all affected product immediately; complete and return the enclosed Recall Acknowledgement & Stock Status Form to their sales representative, and return any affected product freight collect to: Arrow International, Inc., 312 Commerce Place, Asheboro, NC 27203, attn: Asheboro Quality Assurance Manager. Arrow International can provide replacement with a similar product or credit their account. If you have questions or concerns, please call this toll free number 800-233-3187.
Recalling firm
- Firm
- Arrow International Inc
- Address
- 2400 Bernville Road, Reading, Pennsylvania 19605
Distribution
- Distribution pattern
- Nationwide distribution: CT
Timeline
- Recall initiated
- 2011-06-20
- Posted by FDA
- 2011-11-30
- Terminated
- 2012-10-01
- Status
- —
Source: openFDA Device Recall endpoint. Recall record ID #105014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.